People · Operator
Named in public records as an officer, director or promoter · active 2013–2024 · Other Health Care, Biotech, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RxLightning, Inc. | — | Other Health Care | Series B | $25.8M | $160.1M | 2021 |
| Siren Biotechnology, Inc. | — | Biotech | Series B | $19.6M | $154.2M | 2024 |
| 1660 University, LLC | — | Other | Seed | $1.2M | $22.3M | 2013 |
Brad Allen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brad Allen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Bakken | 1 | 24 |
| Sharon Tetlow | 1 | 4 |
| Taha Jangda | 1 | 3 |
| Josh Flum | 1 | 2 |
| Julia Regan | 1 | 1 |
| Kathleen Bresette | 1 | 1 |
| Carrie Williams | 1 | 1 |
| Richard Cohan | 1 | 1 |
| Lance Sigmon | 1 | 1 |
| Nicole Paulk | 1 | 1 |
| Jared Klingeisen | 1 | 1 |
| Bradley Fluegel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.